afatinib
Ligand Summary
A quinazoline and butenamide derivative that acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER.
UNII: 41UD74L59M
PubChem: 10184653
Guide to Pharmacology: 5667
ChEMBL: CHEMBL1173655
DrugCentral: 4318
LyCHI: L93TLR94JUC1
Target Activities
77 Activities
Items per page:
10
1 – 10 of 77
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Kd | ||||||
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||